7-73700778-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001165903.2(STX1A):c.695C>T(p.Pro232Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,613,672 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/15 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001165903.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STX1A | NM_004603.4 | c.741C>T | p.Ala247Ala | synonymous_variant | 9/10 | ENST00000222812.8 | NP_004594.1 | |
STX1A | NM_001165903.2 | c.695C>T | p.Pro232Leu | missense_variant | 9/10 | NP_001159375.1 | ||
STX1A | XM_047420777.1 | c.*104C>T | 3_prime_UTR_variant | 9/9 | XP_047276733.1 | |||
STX1A | XM_047420778.1 | c.*49C>T | 3_prime_UTR_variant | 9/9 | XP_047276734.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STX1A | ENST00000222812.8 | c.741C>T | p.Ala247Ala | synonymous_variant | 9/10 | 1 | NM_004603.4 | ENSP00000222812.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151966Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251366Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135868
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461706Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727170
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151966Hom.: 0 Cov.: 31 AF XY: 0.0000539 AC XY: 4AN XY: 74232
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at